ZA202205323B - Collagen-based sponge for trauma, preparation method thereof, use thereof in preparation of medicament for reducing scar formation in skin repair - Google Patents

Collagen-based sponge for trauma, preparation method thereof, use thereof in preparation of medicament for reducing scar formation in skin repair

Info

Publication number
ZA202205323B
ZA202205323B ZA2022/05323A ZA202205323A ZA202205323B ZA 202205323 B ZA202205323 B ZA 202205323B ZA 2022/05323 A ZA2022/05323 A ZA 2022/05323A ZA 202205323 A ZA202205323 A ZA 202205323A ZA 202205323 B ZA202205323 B ZA 202205323B
Authority
ZA
South Africa
Prior art keywords
preparation
trauma
collagen
medicament
scar formation
Prior art date
Application number
ZA2022/05323A
Inventor
James Curtis Dring
Rui Zhou
Original Assignee
Univ Wenzhou Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wenzhou Medical filed Critical Univ Wenzhou Medical
Publication of ZA202205323B publication Critical patent/ZA202205323B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2022/05323A 2022-03-30 2022-05-13 Collagen-based sponge for trauma, preparation method thereof, use thereof in preparation of medicament for reducing scar formation in skin repair ZA202205323B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210326732.4A CN114632183B (en) 2022-03-30 2022-03-30 Wound protein sponge, preparation method thereof and application of wound protein sponge in preparation of medicines for reducing scar formation in skin repair

Publications (1)

Publication Number Publication Date
ZA202205323B true ZA202205323B (en) 2022-09-28

Family

ID=81952609

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/05323A ZA202205323B (en) 2022-03-30 2022-05-13 Collagen-based sponge for trauma, preparation method thereof, use thereof in preparation of medicament for reducing scar formation in skin repair

Country Status (2)

Country Link
CN (1) CN114632183B (en)
ZA (1) ZA202205323B (en)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1214505B (en) * 1987-03-12 1990-01-18 Gentili Ist Spa PROCEDURE FOR THE PREPARATION OF COLLAGEN AND PRODUCTS SO OBTAINED.
CN101279104B (en) * 2007-04-05 2011-05-11 王珊珊 Preparation of collagen protein sponge containing growth factor
CN102357259A (en) * 2011-07-28 2012-02-22 王珊珊 Bioprotein sponge and preparation method thereof
CN102363798B (en) * 2011-11-15 2013-03-13 无锡贝迪生物工程有限公司 Preparation process for collagen sponge
CN103772734A (en) * 2014-01-17 2014-05-07 哈尔滨工业大学 Preparation method of high-purity collagen protein sponge
CN104926935A (en) * 2014-03-21 2015-09-23 安徽宝迪肉类食品有限公司 Efficient extraction method for extracting collagen from pigskin
CN104645403B (en) * 2015-02-06 2016-04-06 河北途升医疗器械贸易有限公司 A kind of preparation method of collagen protein sponge
CN107012150A (en) * 2017-05-12 2017-08-04 温州医科大学 The assay method of the clone of recombinant human fibroblast growth factor 16, expression and application and its biological activity
CN108014370A (en) * 2017-12-12 2018-05-11 吕振木 A kind of promotion, which is press-offed, injures the collagen material that avulsion skin survives
CN108904861A (en) * 2018-07-23 2018-11-30 天津市长江医疗器械有限公司 Collagen protein sponge promotes application and its physicochemical property detection method in wound healing drug in preparation
CN113354745B (en) * 2021-07-09 2022-10-04 温州医科大学 Composition and method for large-scale production of fibroblast growth factor

Also Published As

Publication number Publication date
CN114632183A (en) 2022-06-17
CN114632183B (en) 2023-02-03

Similar Documents

Publication Publication Date Title
Son et al. Overview of surgical scar prevention and management
RU2018103454A (en) COMPOUNDS OF BENZOXAZEPINOXAZOLIDINONES AND METHODS OF APPLICATION
WO2018121998A3 (en) Non-shivering cryothermogenesis method for reducing adipose tissues
MX2014004458A (en) Threads of cross-linked hyaluronic acid and methods of use thereof.
WO2007079224A3 (en) Sirna compositions promoting scar-free wound healing of skin and methods for wound treatment
NZ586302A (en) Pre-surgical treatment using brimonidine applied topically to reduce bleeding or bruising
AU2011338647A8 (en) Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients
Adani et al. Use of integra artificial dermis to reduce donor site morbidity after pedicle flaps in hand surgery
MX2015011801A (en) Process for obtaining a sprinkling compound of microvascular endothelial skin cells and mesenchymal stem cells and method of application for tissue regeneration.
SG10201807789WA (en) Vaginal composition and use thereof
ZA202205323B (en) Collagen-based sponge for trauma, preparation method thereof, use thereof in preparation of medicament for reducing scar formation in skin repair
RU2015135843A (en) THERAPEUTIC AGAINST HERNIASIS
Jacono A Novel Volumizing Extended Deep-Plane Facelift
EP3476395A4 (en) Composition for injection which can be used for treatment of heart diseases and contains fibroblasts, and method for producing fibroblast for therapy use
EA200970764A1 (en) METHOD OF TREATMENT OF DISORDERS CAUSED BY PROLIFERATION OF CELLS WITH THE USE OF STIMULATORS OF THE GROWTH HORMONE SECRETION
EP3708653A4 (en) Artificial fat tissue and method for producing same, method for producing artificial skin and agent for fat cell culture
EP3884771A4 (en) Composition for reconstituting human skin tissue having hair follicles, human skin tissue model animal, and production method thereof
Özkaya et al. The use of acellular dermal matrix in treatment of mitten hand in epidermolysis bullosa patients
Singh et al. Invasive squamous cell carcinoma in full-thickness burn wounds after treatment with cultured epithelial autografts
AU2023902634A0 (en) Artificial skin tissue
Zhou et al. Clinical efficacy of ultrasound-guided chondroitin polysulfate from bovine trachea combined with fractional CO2 laser in the treatment of scar after burn repair
Messa et al. Posterior Sheath Repair in Abdominal Wall Reconstruction: Achieving Retromuscular Mesh Placement
Hashish et al. Ingrowing Nail Correction by Advancing Composite Flap of the Nailbed and Periosteum—A Simple and Effective
Lee et al. Use of Acellular Allogenic Dermal Matrix in Soft Palate Reconstruction after Excision the Pleomorphic Adenoma
Song et al. Implications of updates Check for Malignancy, Radiation, and Timing of Major Nasal